Elixirgen Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

Elixirgen Therapeutics, Inc. holds 38 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 36 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 4 trademarks are registered and 32 are pending. Notable registered marks include BOBCAT, C-SRRNA, and ELIXIRGEN THERAPEUTICS. The owner is based in Baltimore, MD.